Yuge A

No ORCID on file · 12 papers in corpus · active 2006-2015

Study types

  • article 9
  • review 2

Condition tags

  • endometriosis 10
  • endometrioma 1
2015
Case Reports in Obstetrics and Gynecology ·doi:10.1155/2015/170343

Background. Although radiation exposure is of great concern to expecting patients, little information is available on the fetal radiation dose associated with prophylactic internal iliac artery balloon occlusion (IIABO). Here we estimated t…

article 2014
Japanese clinical medicine ·doi:10.4137/jcm.s12611

Mayer-Rokitanski-Kuster-Hauser (MRKH) syndrome is a rare disease. A 27-year-old woman was admitted for primary amenorrhea and cyclic pelvic pain. Magnetic resonance imaging (MRI) revealed bilateral Müllerian remnants with functioning endome…

review 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719110392059

Endometriosis, a disease affecting 3% to 10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue under the influence of estrogen. It is also becoming recognized as a condition in which ectopic endometr…

article 2011
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2011-1503

CONTEXT: During the development of endometriotic lesions, excess fibrosis may lead to scarring and to the alterations of tissue function that are the characteristic features of this disease. Enhanced extracellular matrix contractility of en…

article 2010
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2010.10.026

ObjectiveEndometriosis is characterized by the ectopic growth of endometrial tissue. One of the first steps to the spread of endometriosis in the peritoneal cavity is the attachment of endometriotic cells to peritoneal surfaces after they h…

article 2009
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2009-0207

CONTEXT: Decidualization of the endometrium involves the morphological and biochemical reprogramming of the estrogen-primed proliferative endometrial stromal compartment under the continuing influence of progesterone. OBJECTIVES: The aim of…

article 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.02.057

ObjectiveTo assess the use of heparin for the medical treatment of endometriosis-associated fibrosis.DesignThe effects of heparin on the endometriotic stromal cells (ECSCs)-mediated contractility were investigated.SettingResearch laboratory…

review 2009
Histology and histopathology ·doi:10.14670/hh-24.1181

Endometriosis, a disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue. Increasingly, endometriosis is also becoming recognized as a condition in which ectopic endometrial cells e…

article 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.06.055

Simvastatin significantly inhibited the proliferation of endometriotic stromal cells, attenuated the collagen gel contraction mediated by these cells, and suppressed endometriotic stromal cell attachment to collagen fibers. Simvastatin is c…

article 2007
Human Reproduction ·doi:10.1093/humrep/del485

BACKGROUND: Excessive fibrosis is frequently associated with endometriosis. To evaluate the involvement of the extracellular matrix contractility of endometriotic stromal cells (ECSCs) in the pathogenesis of endometriosis-associated fibrosi…

article 2006
American journal of physiology. Endocrinology and metabolism ·doi:10.1152/ajpendo.00135.2006

Most of the current medical treatments for endometriosis aim to downregulate estrogen activity. However, a high recurrence rate after medical treatment has been the most significant problem. BAY 11-7085, a soluble inhibitor of NK-kappaB act…

article 2006
Human Reproduction ·doi:10.1093/humrep/del270

BACKGROUND: Most of the current medical treatments for endometriosis aim to down-regulate the estrogen activity. However, a high recurrence rate after medical treatments has been the most significant problem. Beta-hydroxyisovalerylshikonin …